In 2022, the WHO published its first action plan on neurological disorders, marking a milestone towards Brain Health for all. But what does it mean for neurosurgery? What are the challenges and pragmatic solutions involved in making high-quality neurosurgical care universally accessible? Join our distinguished panel of experts as we discuss the effective strategies for diverse settings and gain a comprehensive understanding of the global landscape of neurosurgical care.
Chair: Professor Kee Park, MD, MPH
Director of Policy and Advocacy and Lead, Global Neurosurgery Team, Program in Global Surgery and Social Change, Harvard Medical School
Chair, Global Neurosurgery Committee, World Federation of Neurosurgical Societies
In 2013, Prof Park volunteered with the World Federation of Neurosurgical Societies and the Foundation for International Education in Neurological Surgery to support Cambodian neurosurgeons. As a Consultant in Neurosurgery at the Preah Kossamak Hospital in Phnom Penh and head of the Cambodia Neurosurgery Support Project, he taught neurosurgery and conducted research on head and spine injuries. Prior to Cambodia, he was the Director of Spine Surgery at the Myungsung Christian Medical Center in Addis Ababa, Ethiopia (2009 to 2013).
Speaker: Associate Professor Abenezer Tirsit
Associate Professor of Neurosurgery, Addis Ababa University | Addis Ababa, Ethiopia
He is currently an Associate Professor of Neurosurgery at Addis Ababa University, and had been working as a neurosurgeon at Black Lion Hospital since December 2014. Assoc Prof Tirsit is also a Clinical PhD candidate at the University of Bergen, Norway. He is a member of the following Boards: Ethiopian Medical Association (EMA); WFNS Global neurosurgery committee; EC member of CAANS; and WFNS Senior delegate for Society of Ethiopian Neurological Surgery Professionals. Previously Assoc Prof Tirsit was President of Society of Ethiopian Neurological surgery professional, 2019-2023, and Head of Neurosurgery Division, Department Of Surgery: Addis Ababa University, 2022-2023.
Speaker: Dr Tariq Khan MBBS, FRCS
Neurosurgeon, Northwest General Hospital & Research Centre, Peshawar, Pakistan
Dr. Tariq Khan is the Dean of Northwest School of Medicine located in Peshawar, Pakistan, and a Professor and Head of the Department of Neurosurgery at Northwest General Hospital & Research Centre. Dr. Khan is the immediate past Chair of the Neurotraumatology Committee of the World Federation of Neurosurgical Societies (WFNS). Currently he is the Coordination Lead of the Global Neurosurgery Committee WFNS.
Infections of the central nervous system are life-threatening in children. In this interactive session we will discuss tuberculosis meningitis, the most devastating form of tuberculosis, which even when treated has a 20% mortality rate in children and leaves over 50% of survivors with a neurological disability. We will also discuss ventriculoperitoneal shunt infection, an often-neglected cause of neurological infection in children which is associated with increased risk of seizure disorders, decreased intellectual performance and increased mortality. We invite all clinicians, academics, policy makers and allied professionals who are interested to join.
Chair: Dr Stephen Ray, M.Phil, MRCPCH, MRes, DTM&H, PhD
Clinical Lecturer in Paediatric Infectious Diseases, University of Oxford, UK
Dr Ray is a paediatric registrar, currently undertaking sub-specialty training in paediatric infectious diseases. His research aims to improve the diagnosis, management, and outcomes of critically ill children with life-threatening infections, with a focus on brain infections, particularly in Low-and-Middle-Income Countries (LMIC). Dr Ray’s Wellcome Trust Clinical PhD Fellowship was primarily based in Malawi (2018-2022), collaborating with the Blantyre Malaria Project and Malawi Liverpool Wellcome Trust. During this period he was also PI on a national study investigating the neurological manifestations of COVID in children.
Professor Van Toorn, MD, PhD
Department of Paediatrics and Child Health, Stellenbosch University, South Africa
Prof Ronald van Toorn is a pediatric neurologist. He is currently a full professor of Pediatrics and Child health at Tygerberg Hospital and the Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University (SU). He obtained his MBChB from SU in 1992, MRCP from the Royal College of London in 1996, FCP (Pediatrics) from the College of Medicine in South Africa in 1999 and the Certificate in Pediatric Neurology in 2005. He obtained a PhD on the diagnosis and management of tuberculous meningitis (TBM) in children at Stellenbosch University in 2015. His field of study is pediatric neurology with a research interest in neuro-infectious diseases (especially tuberculous meningitis), neuro-metabolic disease, neonatal neurology and epilepsy, especially its management in resource-constraint settings. His main focus has been in the field of childhood TBM, and his work has added unique insights into the understanding of childhood TBM diagnosis, complications and treatment. He has written on various aspects of TBM, including numerous collaborative reviews and three book chapters. He has more than 100 peer-reviewed publications and a Scopus h-index of 24. He is an established member of the International TBM research consortium and is considered a global expert on Pediatric TBM, which includes a collaborative effort in understanding TBM, epidemiology, diagnostics and complications especially stroke, treatment and advocacy. Last year he contributed to the WHO expert consultation panels on a shorter regimen for pediatric TBM (the WHO has adopted the short 'Cape Town' regimen for drug susceptible TBM in children).
Associate Professor and Paediatric Infectious Diseases Specialist
American Medical Center and St. Paul’s Hospital Millennium Medical College Addis Ababa, Ethiopia
Dr Tinsae Alemayehu is a paediatric infectious diseases specialist and an Associate Professor of Paediatrics based in Addis Ababa, Ethiopia. He also serves as the Vice President of the African Society of Paediatric Infectious Diseases and has been recognized as an emerging leader in infectious diseases by the International Society of Infectious Diseases (ISID) in 2022. His research interests are in paediatric antimicrobial stewardship, congenital infections and inborn errors of immunity.
Patient and public involvement is about patients actively contributing through discussion to decisions about research design, acceptability, relevance, conduct and governance from study conception to dissemination. Occasionally patients lead or do research too. During this meeting, we will hear practical examples from patient organisations and people affected by neurological conditions about their approach and involvement in PPI, and why it is so valuable. Examples will be drawn from a range of settings, including clinical research, public policy and campaigning.
Chair: Georgina Carr | Chief Executive at the Neurological Alliance
Georgina joined the Alliance in January 2020. Prior to this role, Georgina worked for the MS Society, overseeing their work to campaign for improved MS treatment, care and support. Georgina is also patient and public voice representative on the NHS England Neurology Clinical Reference Group and the Co Chair of the Patient and Public Voice Reference Group for the Acquired Brain Injury Strategy.
Georgina has a close connection to MS and traumatic brain injury, and is passionate about raising the bar of neurological treatment, care and support across the country. Prior to working at the UK MS Society, Georgina worked on EU health policy for the consultancy Burson Marsteller.
Speaker: Dr. Ava Easton | Chief Executive, Encephalitis Society
Dr Ava Easton is Chief Executive of The Encephalitis Society, a researcher and global expert on encephalitis patient outcomes and quality of life.
She has produced and published many papers, book chapters, and a book (Life After Encephalitis) on various aspects of encephalitis and its after-effects. She also speaks at conferences and lectures around the world on the condition and its impact for patients and their families.
Her expertise also extends to neuro-narratives, narrative medicine, and patient and public engagement.
Ava is involved in a number of research studies looking into the processes and outcomes of encephalitis and is an Honorary Senior Fellow in the Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, UK.
She is member of the Global Neuro Research Coalition; member of the Steering Committee and Chair of the PPI arm of The COVID-Clinical Neuroscience Study (CNS). She is also Co-Investigator and Chair of the Patient and Public Involvement Panel for the Brain Infections/COVID Neuro Global Study, an Ambassador for the European Brain Injury Council, and a member of the Royal Society of Medicine, the American Academy of Neurology, and the European Academy of Neurology.
Ava acts as a consultant to various media (radio and television) on encephalitis and acquired brain injury.
Speaker: Prof. Dr Bindu Menon | M.D. (Med.), D.M. (Neuro), DNB. (Neuro), PGDCN (Neuro),(London), FRCP (Edinburgh), MNAMS. FICP, FIAN, FWSO, FAAN | www.drbindumenon.com
Prof. Bindu Menon is the Head of Department Apollo Hospitals actively involved in research and outreach activities for stroke and epilepsy. She is member of the Research and world stroke campaign committee member of WSO and a recipient of the Mridha Spirit of Neurology award, A.B. Baker Teacher Recognition, and World Stroke award among others.
She founded the Dr. Bindu Menon foundation; SSO in August 2013, which is a representative of the WHO South East Asia Region and the life time Network member of NCD Alliance. She has been instrumental in starting several novel projects for the first time in the country: “Neurology on wheels”; Tele awareness Programme; Stroke app “Stroke help”; and Epilepsy help app.
June 30 2023
Epilepsy is a chronic non-communicable disease that affects about 50 million people worldwide. According to the World Health Organization, 80% of those affected live in low-middle-income countries, with three-quarters not getting adequate treatment. In addition, those affected face stigma from their community. In this session, experts in the field will discuss the challenges and opportunities of managing epilepsy.
Chair: Professor Gagandeep Singh, MD, AM, FAMS, FRCP (London), FIAN, FICP. Professor & Head, Department of Neurology at Dayanand Medical College, Ludhiana, India. Honorary Associate Professor at UCL, London, UK. Secretary General of Indian Epilepsy Association.
Speaker: Dr Tiwonge Phiri MBBS Neurologist, Queen Elizabeth Central Hospital, Malawi
Learning Objective - Gain insights into practice in different settings through knowledge exchange with fellow participants.
The increasing burden of neurological disorders calls for a prompt and targeted action to improve access to the neurology care worldwide. One of the pillars of the WHO's intersectoral action plan is building capacity in global neurology. Using his experiences from USA and Zambia, Dr Mashina Chomba will discuss strategies on how meaningful improvements can be made on the ground in settings with variable resources.
Chair: Professor Sam Nightingale MBChB, PhD, Associate Professor of Neurology at the University of Cape Town.
Speaker: Dr Mashina Chomba MBChB, MMed Neurology Consultant Neurologist, Department of Internal Medicine at the University Teaching Hospital in Lusaka, Zambia Dr Chomba is one of Zambia's first locally trained neurologists. He graduated from the University of Zambia School of Medicine where he attained his medical degree and later his Master of Medicine degree in Neurology. He also completed a research fellowship in neuroinfectious diseases at Columbia University in New York, USA, in 2021 and is currently an NIH Fogarty Global Health Fellow. Dr Chomba’s research focus is on the epidemiology of neurologic diseases, such as multiple sclerosis, in Zambia and sub-Saharan Africa.
Learning Objective - Gain insights into practice in different settings through knowledge exchange with fellow participants.
The World Health Organization has outlined the need for intersectoral action to improve brain health around the world - but how do we achieve this? Our chair, speaker and panel will discuss using intersectoral approaches in dementia, covering both the healthcare setting and community. We will describe practical approaches that can be taken with limited resource.
Chair: Professor Mohamed Salama MBBCH, DTQM, PhD
Professor at the Institute of Global Health and Human Ecology, the American University in Cairo, Egypt.
Mohamed is leading the Egyptian Longitudinal Study of Aging to try to reshape the current understanding of aging. He obtained his medical degree in 1999 from Mansoura University, Egypt where he began his clinical training. He received his MSc in Toxicology in 2006 and through a DAAD scholarship his PhD degree in Neurotoxicology in 2011 through collaboration with Philipps University in Marburg, Germany.
Speaker: Professor Eléonore Bayen MD, PhD
Professor of Medicine at Sorbonne University and Director of the Neuro-Rehabilitation Department of Pitié-Salpêtrière hospital in Paris.
Eléonore holds a medical degree in Neurology (2008) completed with a qualification in Physical and Rehabilitation Medicine, and a PhD in Economics (2015). She has a dual background in Neurosciences and Health Economics. She has expertise in neurology, in cognitive impairment and in the management of complex disability situations. Her research focuses on synergistic patterns of social-economic and medical handicap and also the impact of multimorbidity in the process of loss of autonomy, including prediction-prevention of disability and of acquired vulnerability according to the ICF - WHO approach. To raise awareness of Brain Health Eléonore launched the MyBrainRobbie initiative in 2019, which aims to empower children and teenagers in the domain of brain health and, more broadly, promote equity in brain health in society at large; it has been translated in 7 languages.
Chair: Dr Nicoline Schiess, MD, MPH Technical Officer, World Health Organisation (WHO), Department of Mental Health and Substance Use, Brain Health Unit.
Nicoline Schiess is a technical officer working in the Brain Health Unit in the Department of Mental Health and Substance Use at the World Health Organization. In this role she serves as the point person for various adult neurological disorders as well as assists in the implementation of the Intersectoral global action plan on epilepsy and other neurological disorders, a global plan of action for neurological disorders.
Dr Marie-Pierre Preziosi MD, PhD Lead Meningitis and Co-Lead R&D Blueprint for Action to prevent epidemics World Health Organisation (WHO), Department of Immunisation, Vaccines and Biologicals.
Dr Preziosi is leading on the Global road map on defeating meningitis by 2030 at the World Health Organization (WHO), as well as co-leading on the R&D Blueprint for action to prevent epidemics. From 2012-2014, she was director of the Meningitis Vaccine Project, a partnership between WHO and PATH, established in 2001. The project mission was to eliminate epidemic meningitis as a public health problem in sub-Saharan Africa through the development, testing, introduction and widespread use of meningococcal conjugate vaccines.
This is an open session for policy makers, academics and clinicians organised by the World Health Organisation (WHO) Neurology & COVID-19 Global Forum and The Global Health Network.
This interactive session will discuss different tools to ensure neurological health care is universal for all. Including a global inter-observer variability study reviewing the in-patient Case Record Form used by the COVID-CNS team, supported by the WHO and WFN and conducted across 14 countries in high, middle and low income settings.
Chair: Prof. Njideka Okubadejo, MBChB, FMCP, FAAN | Professor of Neurology and Consultant Neurologist specializing in Movement Disorders at the College of Medicine, University of Lagos, Nigeria.
She is the first female neurologist and first female tenured Professor of Neurology in Nigeria. Her main research interest is in Movement Disorders in Africa (particularly genetics and epidemiology).
Speaker: Dr Arina Tamborska, MD National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool and Department of Neurology, Walton Centre NHS Foundation Trust, Liverpool
Dr Arina Tamborska is an academic clinical fellow in neurology at the University of Liverpool and a neurology registrar at the Walton Centre NHS Foundation Trust. Following graduation from Edinburgh Medical School, she pursued academic clinical training at King’s College London before moving to Liverpool. Her research interests include neurovascular disease, neuroepidemiology and developing tools for clinical research harmonisation. Learning Objective -Gain insights into practice in different settings through knowledge exchange with fellow participants
Dr Sundus Alusi, Consultant Neurologist, The Walton Centre, Liverpool UK.Dr Alusi subspecialises in movement disorders including Huntington's Disease, Deep brain stimulation and tremor disorders. She was the clinical lead for movement disorders at The Walton Centre 2020-2022.
Speaker: Dr Nestor Nsengiyumva, MD, Neurology lecturer, Hope Africa University Faculty of Health Sciences, Bujumbura, Burundi, Honorary Neurology Consultant, Burundi National Police Hospital, Bujumbura, Burundi
Dr Nestor Nsengiyumva is a Consultant Neurologist in Burundi. He did a six month clinical training fellowship in Movement Disorder at The Walton Centre NHS Foundation Trust, Liverpool, UK with Dr. Sundus Alusi and Dr. Antonella Macerollo in 2019-2020, funded by the International Parkinson and Movement Disorder Society, European Section.
In this highly interactive session we will discuss several clinically relevant questions on the association of COVID-19 with epilepsy/seizures:
Chair: Professor Alla Guekht MD, PhD, Director of the Moscow Research and Clinical Center for Neuropsychiatry and Professor of Neurology at the Russian National Research Medical University.
Her main research interests are focused on epilepsy after stroke and traumatic brain injury, somatic and psychiatric co-morbidities in epilepsy, social issues (epidemiology, QOL, stigma). She is Elected trustee of the World Federation of Neurology, Treasurer of the International League against epilepsy, co-chair of the “Follow-up and long term impact working group meeting COVID-19 NeuroForum”. She has been involved in many WHO projects in epilepsy and brain health.
Speaker: Professor Ali A. Asadi-Pooya, M.D. Dr. Asadi-Pooya is a Professor of Epileptology, at the Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran. He is also an Adjunct Research Associate Professor of Neurology, Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. He did his fellowship in “epilepsy and clinical neurophysiology” at Thomas Jefferson University, Philadelphia, USA in 2006-2008, and a second epilepsy fellowship on “Invasive intracranial EEG monitoring” in 2014-2016.
He has established an Epilepsy Care Unit and epilepsy surgery program with a multidisciplinary team in 2008 at Namazee Hospital, Shiraz, Iran. He has also founded the Shiraz Epilepsy Research Center in 2020. He has published more than 290 papers and 12 books about various aspects of epilepsy.
One Health uses an interdisciplinary and at times transdisciplinary approach to look at the interconnection of human, animal and environmental health in the context of infectious and non-infectious diseases and beyond. The One Health concept is hardly ever used in the context of neurological disorders but has recently gained traction through its inclusion in the WHO Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders. This will attract attention but foremost curiosity about how the One Health concept could best be implemented for neurological disorders. We will shine some light on this intriguing approach by presenting classical One Health neurological cases such as rabies and neurocysticercosis.
Chair: Prof. Dr. Dr. Andrea S. Winkler
Co(joint)-director Center for Global Health, Technical University of Munich, Germany
Prof. Winkler is a specialist neurologist, a senior researcher and the co(joint)-director of the Center for Global Health at the Technical University of Munich. She is also the founding director, now deputy director, of the Centre for Global Health at the University of Oslo, where she holds a full professorship in Global Health. Prof. Winkler has 20 years of experience with both clinical work and research in countries of sub-Saharan Africa. Her special interest lies with poverty-related neglected diseases of the infectious as well as non-infectious nature, global neurology/mental health and global One Health.
Speaker: Assoc Prof. Dr. Fan Kee Hoo, MRCP
Associate Professor, Department of Neurology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia
Associate Professor Dr. Hoo Fan Kee is a neurologist, general physician and senior lecturer at the University Putra Malaysia. He is currently the chairman of Malaysian Stroke Council and ex officio member of Malaysian Society of Neuroscience.
This interactive session covered critical care of the neurologic system.
Chair: Assistant Professor (Dr) Sherry H-Y Chou, Associate Professor of Neurology (Neurocritical Care). Chief of Neurocritical Care in the Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Dr. Sherry Chou is a physician-scientist with expertise in clinical neurology, neurocritical care and vascular neurology and award-winning mentor. Dr. Chou founded and leads the large Global Consortium Study on Neurological Dysfunction in COVID 19 (GCS-NeuroCOVID) and serves as an invited member to the World Health Organization forum on neurological impacts of COVID 19.
Speaker: Dr Ayush Batra, MD
Assistant Professor Department of Neurology (Neurocritical Care) and Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Ayush Batra, MD, is an assistant professor in the Department of Neurology and Pathology at Northwestern University Feinberg School of Medicine and practicing Neurocritical Care Physician at Northwestern Memorial Hospital in Chicago, IL, USA. He completed his neurology training at the combined Brigham and Women’s and Massachusetts General Hospital, Harvard University, in Boston, MA, USA, where he subsequently completed fellowship training in Neurocritical Care. Dr. Batra’s research interests bridge immunology, vascular biology, and neuroscience, and seek to understand inflammation-mediated mechanisms of acute neurologic injury.
-Gain insights into practice in different settings through knowledge exchange with fellow participants
27 May 2022
This interactive session will cover pathophysiology, epidemiology, diagnosis, management and prognosis of major infections of the brain, including meningitis, encephalitis and abscess. We will additionally discuss acute involvement of the nervous system in COVID-19.
Chair: Dr Benedict Michael
Speaker: Dr Bhagteshwar Singh, MBChB MRCP DTMH
Lead fellow for the NIHR Global Health Research Group on Brain Infections & MRC-funded COVID-Neuro Global research programme in Brazil, India and Malawi.
Clinical Research Fellow in the Liverpool Brain Infections Group, and senior clinical trainee in Infectious Diseases.
29 April 2022
In this interactive workshop, we will discuss the detection and characterisation of headache in high, medium, and lower income settings.
This is an open session for policy makers, academics and clinicians organised by The Global Health Network.
Chair: David García-Azorín MD PhD MSci
Department of Neurology, Hospital Clínico Universitario de Valladolid, Spain. Spanish Society of Neurology board.
Professor, Dr. Med. Director Rigmor Højland Jensen, Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup, University of Copenhagen
Dr. Marcio Nattan Souza, Coordinator of the Headache Fellowship Program at University of São Paulo and member of the Education Committee of the International Headache Society.
-Gain insights into practice in different settings through knowledge exchange with fellow participants
25 March 2022
In this interactive workshop, Assoc Prof Roa will discuss clinical cases in paediatric neurology, including pediatric NeuroCOVID/MIS-C. This is an open session for policy makers, academics and clinicians.
Chair: Ass Prof (Dr) Ericka Fink
Associate Professor of Critical Care Medicine and Paediatrics, Dept of Critical Medicine, University of Pittsburgh, USA.
Speaker: Assoc Prof Juan David Roa, MD MSc
Associate Professor of Paediatric Neurology and Paediatric Intensive care, Universidad Nacional de Colombia, LARed Network, SLACIP
25 February 2022
In this interactive workshop, Asst Prof Omar Siddiqi will discuss the approaches taken to the encephalopathic patient in high, medium, and lower income settings.
This is an open session for policy makers, academics and clinicians.
Asst Prof (Dr) Omar Siddiqi:
Assistant Professor of Neurology & Director of Global Neurology Program, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, USA.
Prof (Dr) Kameshwar Prasad:
Professor of Neurology. Director & Chief Executive Officer, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
24 January 2022 | 2 PM (London, GMT)
Prof Aaron Berkowitz: Professor and Director of Global Health, Kaiser Permanente School of Medicine (USA); Health and Policy Advisor, Partners In Health; Senior Specialist Consultant, Medecins Sans Frontieres/Doctors Without Borders
Dr Kiran Thakur: Neurologist, Columbia University Irving Medical Center, USA Consultant, World Health Organisation: Brain Health Unit
Dr. Biniyam A. Ayele: Department of Neurology, Addis Ababa University, Addis Ababa, Ethiopia Post-Doctoral Neuroinfectious Fellow, Columbia University Irving Medical Center, NY, USA
Decision Analysis to Address Clinical Dilemmas in Resource-Limited Settings, Aaron Berkowitz MD PhD | Download presentation [pdf 1.8mb]
30 November | 2 PM (London, GMT)
In this interactive workshop, Dr James Sejvar from the U.S. Centers for Disease Control and Prevention (CDC), will use a recent outbreak investigation to outline how public health professionals go about solving medical mysteries.
The Brain Health Clinical Exchange is co-organised by the World Health Organisation (WHO) Neurology & COVID-19 Global Forum and The Global Health Network.